293 related articles for article (PubMed ID: 24032760)
1. IgG4-related disease with cutaneous manifestations treated with rituximab: case report and literature review.
Jalilian C; Prince HM; McCormack C; Lade S; Cheah CY
Australas J Dermatol; 2014 May; 55(2):132-6. PubMed ID: 24032760
[TBL] [Abstract][Full Text] [Related]
2. Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.
Ueda K; Ikeda K; Ogawa K; Sukegawa M; Sano T; Kimura S; Suzuki O; Hashimoto Y; Takeishi Y
J Med Case Rep; 2016 Aug; 10(1):236. PubMed ID: 27557810
[TBL] [Abstract][Full Text] [Related]
3. IgG4-related disease with hypergammaglobulinemic hyperviscosity and retinopathy.
Wong PC; Fung AT; Gerrie AS; Moloney G; Maberley D; Rossman D; White V; Collins D; Coupland R; Chen LY
Eur J Haematol; 2013 Mar; 90(3):250-6. PubMed ID: 23278107
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin G4-related disease and its skin manifestations.
Takayama R; Ueno T; Saeki H
J Dermatol; 2017 Mar; 44(3):288-296. PubMed ID: 28256769
[TBL] [Abstract][Full Text] [Related]
5. Case of immunoglobulin G4-related skin disease: possible immunoglobulin G4-related skin disease cases in cutaneous pseudolymphoma only by immunohistochemical analysis.
Iwata Y; Mizoguchi Y; Takahashi M; Tanaka B; Kuroda M; Yagami A; Matsunaga K
J Dermatol; 2013 Dec; 40(12):998-1003. PubMed ID: 24303847
[TBL] [Abstract][Full Text] [Related]
6. IgG4-related Sclerosing disease: a potential new etiology of cutaneous pseudolymphoma.
Cheuk W; Lee KC; Chong LY; Yuen ST; Chan JK
Am J Surg Pathol; 2009 Nov; 33(11):1713-9. PubMed ID: 19701072
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous and systemic IgG4-related disease: a review for dermatologists.
Shenoy A; Mohandas N; Gottlieb A
Dermatol Online J; 2019 Jun; 25(6):. PubMed ID: 31329383
[TBL] [Abstract][Full Text] [Related]
8. IgG4-related skin lesions: case report and review of the literature.
Kempeneers D; Hauben E; De Haes P
Clin Exp Dermatol; 2014 Jun; 39(4):479-83. PubMed ID: 24758575
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous manifestations of IgG4-related disease (RD): A systematic review.
Charrow A; Imadojemu S; Stephen S; Ogunleye T; Takeshita J; Lipoff JB
J Am Acad Dermatol; 2016 Jul; 75(1):197-202. PubMed ID: 26946983
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous plasmacytosis as a skin manifestation of IgG4-related disease.
Yamaguchi H; Moriki M; Ito T; Tokura Y
Eur J Dermatol; 2013; 23(4):560-2. PubMed ID: 23985356
[No Abstract] [Full Text] [Related]
11. Abnormal expression of CD20 on IgG4 plasma cells associated with IgG4-related lymphadenopathy.
Grimm KE; Bakke A; O'Malley DP
Arch Pathol Lab Med; 2013 Sep; 137(9):1282-5. PubMed ID: 23991741
[TBL] [Abstract][Full Text] [Related]
12. IgG4-related skin manifestations in patients with IgG4-related disease.
Ikeda T; Oka M; Shimizu H; Hatakeyama M; Kanki H; Kunisada M; Tsuji G; Morinobu A; Kumagai S; Azumi A; Negi A; Nishigori C
Eur J Dermatol; 2013 Apr; 23(2):241-5. PubMed ID: 23557874
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous multicentric Castleman's disease mimicking IgG4-related disease.
Takeuchi M; Sato Y; Takata K; Kobayashi K; Ohno K; Iwaki N; Orita Y; Yoshino T
Pathol Res Pract; 2012 Dec; 208(12):746-9. PubMed ID: 23102767
[TBL] [Abstract][Full Text] [Related]
14. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review.
Wallace ZS; Deshpande V; Stone JH
Semin Arthritis Rheum; 2014 Jun; 43(6):806-17. PubMed ID: 24513111
[TBL] [Abstract][Full Text] [Related]
15. [IgG4-related disease: patient group characterization and rituximab therapy].
Sedyshev SKh; Vasil'ev VI; Kovrigina AM; Logvinenko OA; Rodionova EB; Safonova TN; Gaĭduk IV; Silin AIu; Komov DV; Nasonov EL
Ter Arkh; 2013; 85(2):48-53. PubMed ID: 23653939
[TBL] [Abstract][Full Text] [Related]
16. High ratio of IgG4-positive plasma cell infiltration in cutaneous plasmacytosis--is this a cutaneous manifestation of IgG4-related disease?
Miyagawa-Hayashino A; Matsumura Y; Kawakami F; Asada H; Tanioka M; Yoshizawa A; Mikami Y; Kotani H; Nakashima Y; Miyachi Y; Manabe T
Hum Pathol; 2009 Sep; 40(9):1269-77. PubMed ID: 19386351
[TBL] [Abstract][Full Text] [Related]
17. IgG4-related skin disease, a mimic of angiolymphoid hyperplasia with eosinophilia.
Hamaguchi Y; Fujimoto M; Matsushita Y; Kitamura-Sawada S; Kawano M; Takehara K
Dermatology; 2011; 223(4):301-5. PubMed ID: 22269779
[TBL] [Abstract][Full Text] [Related]
18. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients.
Khosroshahi A; Carruthers MN; Deshpande V; Unizony S; Bloch DB; Stone JH
Medicine (Baltimore); 2012 Jan; 91(1):57-66. PubMed ID: 22210556
[TBL] [Abstract][Full Text] [Related]
19. Abundant immunoglobulin (Ig)G4-positive plasma cells in interstitial pneumonia without extrathoracic lesions of IgG4-related disease: is this finding specific to IgG4-related lung disease?
Ikeda S; Sekine A; Baba T; Okudela K; Iwasawa T; Sakai F; Notohara K; Ohashi K; Takemura T; Ogura T
Histopathology; 2017 Jan; 70(2):242-252. PubMed ID: 27485309
[TBL] [Abstract][Full Text] [Related]
20. Investigations of IgG4-related disease involving the skin.
Yamada K; Hamaguchi Y; Saeki T; Yagi K; Ito N; Kakuchi Y; Yamagishi M; Takehara K; Nakanuma Y; Kawano M
Mod Rheumatol; 2013 Sep; 23(5):986-93. PubMed ID: 23111461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
